Genmab A/S filed updated Articles of Association effective May 12, 2026, detailing current share capital of DKK 62,353,067 and Board authorizations for capital increases and warrants.
Key takeaways
Share capital is DKK 62,353,067 divided into DKK 1 shares.
Board authorized until March 12, 2029, to increase share capital by up to DKK 6,600,000 without or with pre-emption rights.
Board authorized until March 12, 2029, to issue convertible debt instruments convertible into up to DKK 3,000,000 new shares.
Warrant authorizations: 2021 (expires April 12, 2026, 854,194 warrants issued), 2024 (expires March 12, 2029, 780,310 warrants issued), 2025 (expires March 11, 2030, 33,515 warrants issued).
Combined capital increase authorizations limited to DKK 6,600,000 nominal.
Group language is English; registered office in Copenhagen municipality.